18 may 2018 | Updated 09 jun 2025
-
Priority patent application filed in December 2017. INCLIVA Innovation Unit uai@incliva.es Researchers from INCLIVA has synthesised a novel family of drug candidates with dual PPAR-alpha/ activity....
05 feb 2018 | Updated 09 jun 2025
-
BIMCV, in cooperation with the different fondations of biomedical research dependent on the Conselleria de Sanitat Universal i Salud Pública and other institutions bring together expertise on...
05 feb 2018 | Updated 09 jun 2025
-
The technology has been filed under patent application to the European Patent Office, with priority date 07/12/2016, adn in co-ownership with the Vall d'Hebron Institute of Oncology Private...
05 feb 2018 | Updated 09 jun 2025
-
We have the know and experience of our professionals to approach each and every one of the stages of the study, from its design and advice to interpretation results. All protocols are standardized...